# Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. and Foreign Patents and Patent Applications Concerning Indolo [2,1-B] Quinazole-6,12-Dione Antimalarial Compounds and Methods of Treating Malaria
**AGENCY:**
Department of the Army, DOD.
**ACTION:**
Notice.
**SUMMARY:**
In accordance with 37 CFR Part 404.6 and 404.7, announcement is made of the availability for licensing of inventions set forth in the following, related patent applications:
1. *Title:* Indolo [2,1-B] Quinazole-6, 12-Dione Antimalarial Compounds and Methods of Treating Malaria.
*U.S. Patent No.:* 6,531,487.
*Issued:* March 11, 2003.
2. *Title:* Indolo [2,1-B] Quinazole-6, 12-Dione Antimalarial Compounds and Methods.
*U.S. Patent No.:* 6,284,772.
*Issued:* September 28, 1999.
Foreign rights are also available. The United States Government, as represented by the Secretary of the Army, has rights in these inventions.
**ADDRESSES:**
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.
**FOR FURTHER INFORMATION CONTACT:**
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Applications, (301) 619-6664, both at telefax (301) 619-5034.
Luz D. Ortiz,
Army Federal Register Liaison Officer.